Combined with the molecular weight argument (semaglutide is too large to easily cross biological barriers into milk) and the poor oral bioavailability (any swallowed semaglutide would be destroyed in the infant gut), the safety profile looks reassuring
Discuss any concerns with your healthcare provider, who can help you make an informed decision based on your individual health situation
Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) subcutaneous injection Initial FDA Approval: 2016 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
Its bland nature is gentle on the stomach, making it suitable for those experiencing nausea
The consistent theme is restraint: hold the per-dose amount steady, use frequency and cycle structure as the adjustable variables, and build in breaks
Effectiveness of Henry Meds Semaglutide User reviews on Henry Meds semaglutide are mixed, with many patients reporting significant weight loss and improved blood sugar control, while others experience inconsistent results